SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-063347
Filing Date
2020-12-14
Accepted
2020-12-14 19:24:11
Documents
2
Period of Report
2020-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3963
2 POA DOCUMENT poa.txt EX-24.4_950025 2119
  Complete submission text file 0001209191-20-063347.txt   7603
Mailing Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 981952141
Business Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 981952141 5095927191
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O DORMAN PRODUCTS, INC. 3400 EAST WALNUT STREET COLMAR PA 18915
Business Address
Romano Kelly A (Reporting) CIK: 0001722055 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39503 | Film No.: 201387774